|
|||||
       |
NBI is showing signs of life, rising somewhat from its low point for the year and since the end of the third quarter, but still down almost 12 percent since the start of the year. . . . → Read More: Infographic – Biotech Index Struggles to Regain Ground 
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells. . . . → Read More: Company Started for Gene Editing Rare Inherited Diseases 
Engineers and neuroscientists developed a circuit that in lab mice connects implanted lab-grown brain tissue to the brain’s cognitive center and responds to visual stimuli. . . . → Read More: Implanted Organoid Connects to Brain, Reacts to Visual Cues  Comments are closed  New products  biomedical, computer science, engineering, life sciences, materials science, medical device, physical sciences, preclinical, semiconductors, stem cells, university 
The opioid overdose drug naloxone in nasal spray form is receiving priority review from the Food and Drug Administration as an over-the-counter drug. . . . → Read More: Over-the-Counter Naloxone Receiving Faster FDA Review Comments are closed New products, Regulations biomedical, chemistry, clinical trials, FDA, health care, medical device, pharmaceuticals, physical sciences 
A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations, New products Asia, biomedical, biotechnology, cancer, chemistry, Japan, licensing, life sciences, pharmaceuticals, physical sciences, university 
Funding for new enterprises creating products and services that treat or detect cancer fell more than 40 percent from last year. . . . → Read More: Infographic – Cancer Start-Up Venture Funds Decline One comment - (Comments are closed) Finance biomedical, cancer, economics, entrepreneurs, equity, investment, life sciences, medical device, pharmaceuticals, statistics, venture capital 
A new company creating protein ingredients for food products from carbon dioxide converted by engineered bacteria is raising €4 million more in seed funds. . . . → Read More: Food Protein Biotech Adds €4M in Seed Funds Comments are closed Finance, New products agriculture, biotechnology, chemistry, energy, entrepreneurs, equity, Europe, investment, life sciences, physical sciences, university, venture capital 
Two providers of technologies for cellular analysis are merging to form a new company focusing on cell biology research tools, in a sign of continued industry consolidation. . . . → Read More: Cell Biology Tools Companies Merge in $57.8M Deal Comments are closed Finance biomedical, biotechnology, chemistry, engineering, equity, investment, life sciences, merger, physical sciences 
A new company developing 3-D cell and tissue models of lymph nodes for discovery of immunotherapies is raising $4.3 million in seed funds. . . . → Read More: Immune Organoid Company Raises $4.3M in Seed Funds Comments are closed Finance, New products biomedical, biotechnology, engineering, entrepreneurs, equity, investment, life sciences, mathematics, pharmaceuticals, physical sciences, university, venture capital 
A new business that provides personalized allergy testing, drug making, and delivery to consumers is raising $16.5 million in its first venture funding round. . . . → Read More: Personal Allergy Start-Up Gains $16.5M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, engineering, entrepreneurs, equity, investment, life sciences, medical device, pharmaceuticals, software, venture capital |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts